US Stock MarketDetailed Quotes

ALRN Aileron Therapeutics

Watchlist
  • 3.7700
  • -0.0800-2.08%
Close May 17 16:00 ET
  • 3.8000
  • +0.0300+0.80%
Post 16:00 ET
81.39MMarket Cap-1167P/E (TTM)

Aileron Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-44.49%15.35M
55.26%7.3M
-69.50%1.98M
-74.13%2.08M
-52.63%3.99M
3.92%27.65M
-31.00%4.7M
-4.55%6.48M
33.82%8.04M
20.49%8.42M
Selling and administrative expenses
17.32%11.36M
131.64%5.33M
-12.84%1.96M
-27.42%1.89M
-13.81%2.18M
0.86%9.68M
2.04%2.3M
-10.74%2.24M
20.96%2.61M
-5.42%2.53M
-General and administrative expense
17.32%11.36M
131.64%5.33M
-12.84%1.96M
-27.42%1.89M
-13.81%2.18M
0.86%9.68M
2.04%2.3M
-10.74%2.24M
20.96%2.61M
-5.42%2.53M
Research and development costs
-77.79%3.99M
-17.90%1.97M
-99.48%22K
-96.56%187K
-69.29%1.81M
5.64%17.97M
-47.34%2.4M
-0.91%4.24M
41.01%5.43M
36.54%5.89M
Operating profit
44.49%-15.35M
-55.26%-7.3M
69.50%-1.98M
74.13%-2.08M
52.63%-3.99M
-3.92%-27.65M
31.00%-4.7M
4.55%-6.48M
-33.82%-8.04M
-20.49%-8.42M
Net non-operating interest income expense
400K
78K
40.91%155K
128.57%112K
161.90%55K
423.81%110K
157.89%49K
50.00%21K
Non-operating interest income
--400K
--78K
40.91%155K
128.57%112K
161.90%55K
----
----
423.81%110K
157.89%49K
50.00%21K
Other net income (expense)
-328.93%-728K
-117.56%-59K
-225.00%-5K
181K
-3,740.91%-845K
-27.89%318K
373.24%336K
-93.94%4K
-22K
Gain on sale of security
--200K
----
----
----
----
----
----
----
----
----
Special income (charges)
---928K
--12K
---6K
--88K
---1.02M
--0
--0
--0
--0
--0
-Less：Restructuring and merger&acquisition
--928K
---12K
--6K
---88K
--1.02M
--0
--0
--0
--0
--0
Other non- operating income (expenses)
----
----
-75.00%1K
--93K
904.55%177K
-27.89%318K
373.24%336K
-93.94%4K
----
---22K
Income before tax
42.64%-15.68M
-60.17%-7.28M
71.31%-1.83M
77.64%-1.79M
43.26%-4.78M
-4.45%-27.33M
33.12%-4.55M
5.01%-6.37M
-40.56%-7.99M
-20.75%-8.42M
Income tax
Net income
42.64%-15.68M
-60.17%-7.28M
71.31%-1.83M
77.64%-1.79M
43.26%-4.78M
-4.45%-27.33M
33.12%-4.55M
5.01%-6.37M
-40.56%-7.99M
-20.75%-8.42M
Net income continuous Operations
42.64%-15.68M
-60.17%-7.28M
71.31%-1.83M
77.64%-1.79M
43.26%-4.78M
-4.45%-27.33M
33.12%-4.55M
5.01%-6.37M
-40.56%-7.99M
-20.75%-8.42M
Minority interest income
Net income attributable to the parent company
42.43%-15.73M
-61.40%-7.34M
71.31%-1.83M
77.64%-1.79M
43.26%-4.78M
-4.45%-27.33M
33.12%-4.55M
5.01%-6.37M
-40.56%-7.99M
-20.75%-8.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
42.43%-15.73M
-61.40%-7.34M
71.31%-1.83M
77.64%-1.79M
43.26%-4.78M
-4.45%-27.33M
33.12%-4.55M
5.01%-6.37M
-40.56%-7.99M
-20.75%-8.42M
Basic earnings per share
43.19%-3.42
-57.00%-1.57
71.43%-0.4
77.84%-0.39
43.55%-1.05
-2.21%-6.02
32.89%-1
0.00%-1.4
-46.67%-1.76
-16.25%-1.86
Diluted earnings per share
43.19%-3.42
-57.00%-1.57
71.43%-0.4
77.84%-0.39
43.55%-1.05
-2.21%-6.02
32.89%-1
0.00%-1.4
-46.67%-1.76
-16.25%-1.86
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -44.49%15.35M55.26%7.3M-69.50%1.98M-74.13%2.08M-52.63%3.99M3.92%27.65M-31.00%4.7M-4.55%6.48M33.82%8.04M20.49%8.42M
Selling and administrative expenses 17.32%11.36M131.64%5.33M-12.84%1.96M-27.42%1.89M-13.81%2.18M0.86%9.68M2.04%2.3M-10.74%2.24M20.96%2.61M-5.42%2.53M
-General and administrative expense 17.32%11.36M131.64%5.33M-12.84%1.96M-27.42%1.89M-13.81%2.18M0.86%9.68M2.04%2.3M-10.74%2.24M20.96%2.61M-5.42%2.53M
Research and development costs -77.79%3.99M-17.90%1.97M-99.48%22K-96.56%187K-69.29%1.81M5.64%17.97M-47.34%2.4M-0.91%4.24M41.01%5.43M36.54%5.89M
Operating profit 44.49%-15.35M-55.26%-7.3M69.50%-1.98M74.13%-2.08M52.63%-3.99M-3.92%-27.65M31.00%-4.7M4.55%-6.48M-33.82%-8.04M-20.49%-8.42M
Net non-operating interest income expense 400K78K40.91%155K128.57%112K161.90%55K423.81%110K157.89%49K50.00%21K
Non-operating interest income --400K--78K40.91%155K128.57%112K161.90%55K--------423.81%110K157.89%49K50.00%21K
Other net income (expense) -328.93%-728K-117.56%-59K-225.00%-5K181K-3,740.91%-845K-27.89%318K373.24%336K-93.94%4K-22K
Gain on sale of security --200K------------------------------------
Special income (charges) ---928K--12K---6K--88K---1.02M--0--0--0--0--0
-Less：Restructuring and merger&acquisition --928K---12K--6K---88K--1.02M--0--0--0--0--0
Other non- operating income (expenses) ---------75.00%1K--93K904.55%177K-27.89%318K373.24%336K-93.94%4K-------22K
Income before tax 42.64%-15.68M-60.17%-7.28M71.31%-1.83M77.64%-1.79M43.26%-4.78M-4.45%-27.33M33.12%-4.55M5.01%-6.37M-40.56%-7.99M-20.75%-8.42M
Income tax
Net income 42.64%-15.68M-60.17%-7.28M71.31%-1.83M77.64%-1.79M43.26%-4.78M-4.45%-27.33M33.12%-4.55M5.01%-6.37M-40.56%-7.99M-20.75%-8.42M
Net income continuous Operations 42.64%-15.68M-60.17%-7.28M71.31%-1.83M77.64%-1.79M43.26%-4.78M-4.45%-27.33M33.12%-4.55M5.01%-6.37M-40.56%-7.99M-20.75%-8.42M
Minority interest income
Net income attributable to the parent company 42.43%-15.73M-61.40%-7.34M71.31%-1.83M77.64%-1.79M43.26%-4.78M-4.45%-27.33M33.12%-4.55M5.01%-6.37M-40.56%-7.99M-20.75%-8.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 42.43%-15.73M-61.40%-7.34M71.31%-1.83M77.64%-1.79M43.26%-4.78M-4.45%-27.33M33.12%-4.55M5.01%-6.37M-40.56%-7.99M-20.75%-8.42M
Basic earnings per share 43.19%-3.42-57.00%-1.5771.43%-0.477.84%-0.3943.55%-1.05-2.21%-6.0232.89%-10.00%-1.4-46.67%-1.76-16.25%-1.86
Diluted earnings per share 43.19%-3.42-57.00%-1.5771.43%-0.477.84%-0.3943.55%-1.05-2.21%-6.0232.89%-10.00%-1.4-46.67%-1.76-16.25%-1.86
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg